天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Organic Chemistry>Amides>Amides>GSK2982772
GSK2982772
  • GSK2982772

GSK2982772

Price $1
Package 1KG
Min. Order: 1KG
Supply Ability: 1lg; 2kg; 5kg; 10kg; 100kg
Update Time: 2019-09-02

Product Details

Product Name: GSK2982772 CAS No.: 1622848-92-3
Min. Order: 1KG Purity: 98%
Supply Ability: 1lg; 2kg; 5kg; 10kg; 100kg Release date: 2019/09/02
Product number: Crystal-Liu
Product Name:
GSK2982772
Synonyms:
1622848-92-3;(S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide;GSK2982772
CAS:
1622848-92-3
MF:
C20H19N5O3
MW:
377.39656
EINECS:
 
Product Categories:
 
Mol File:
1622848-92-3.mol
Article illustration
 
GSK2982772 Chemical Properties
 
Safety Information
MSDS Information
 
 
GSK2982772 Usage And Synthesis
Description
(S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide, also known as GSK2982772, is a first-in-class receptor interacting protein 1(RIP1)-kinase specific clinical candidate for the treatment of inflammatory disease. It is an inhibitor of RIP1 that regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases. It has excellent activity in blocking many TNF-dependent cellular responses. Highlighting its potential as a novel anti-inflammatory agent, the inhibitor was also able to reduce spontaneous production of cytokines from human ulcerative colitis explants. 
References
Harris, P. A., et al. "Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases." Journal of Medicinal Chemistry 60.4(2017):1247-1261.
Jeong, Jae Uk, et al. "Synthesis of ( S )-3-amino-benzo[ b ][1,4]oxazepin-4-one via Mitsunobu and S N Ar reaction for a first-in-class RIP1 kinase inhibitor GSK2982772 in clinical trials." Tetrahedron Letters 58.23(2017):2306-2308.

Company Profile Introduction

Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals. Mainly deals in the sales of: Pharmaceutical intermediates OLED intermediates: Pharmaceutical intermediates; OLED intermediates;

Recommended supplier

Product name Price   Suppliers Update time
$68.00/1mg
VIP5Y
TargetMol Chemicals Inc.
2024-11-19
  • Since: 2014-12-17
  • Address: No.967,15th Floor,Unit 7, Building 1, No.70 of DianChang Road, High-tech Development Zone, Zhengzho
INQUIRY
楊俊青

sales@coreychem.com